News summaryJ-Star Holding via GlobeNewswireOct 24, 2026, 12:00 PM

Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

INCYcorporate_transactionspharmaceuticalshealthcare

Genmab and Incyte have entered into a clinical trial collaboration to evaluate the combination of petosemtamab and INCB161734 in patients with KRAS G12D-mutated metastatic colorectal cancer.